Clinical Trials Directory

Trials / Completed

CompletedNCT00969280

Acupuncture for Dry Eye Syndrome

Acupuncture for Dry Eye Syndrome : A Randomized, Patient-Assessor Blinded, Non-acupuncture Point Shallow Penetration-Controlled Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Korea Institute of Oriental Medicine · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is about the effectiveness of acupuncture treatment on dry eye syndrome. Study hypothesis is that a standardized acupuncture would be more effective than a sham acupuncture in dry eye syndrome patients. This is a randomized, patients-assessor blinded, sham acupuncture controlled study. Additionally, the investigators will assess the safety of acupuncture treatment.

Conditions

Interventions

TypeNameDescription
DEVICEStandardized AcupunctureAcupuncture treatment will be applied 3 times per week, total 9 times for 3 weeks. According to the guideline of WHO standard acupuncture point locations in the western pacific region, acupuncture treatment will be offered in all 17 acupoints: both BL2, GB14, TE23, Extra-1(Taiyang), ST1 and GB 20, and GV23, and Left SP3, LU9, LU10 and HT8, which are located in periorbit, forehead or temple of the head and Lt. forearm and back of the Lt. foot by a disposable 20\*30mm (Dongbang Co., korea) acupuncture needle. All the acupuncture needles will be inserted, induced strong 'deqi' sensation and retained for 20 minutes.
DEVICENon-acupuncture point shallow penetration acupunctureAcupuncture treatment will be applied 3 times per week, all 9 times for 3 weeks. Acupuncture treatment will be offered in 17 non-acupuncture points by a disposable 20\*30mm acupuncture needle. A strong 'deqi' sensation will not be induced, but inserted acupunctures will be leaved for 20 minutes.

Timeline

Start date
2009-09-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2009-09-01
Last updated
2010-12-21
Results posted
2010-09-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00969280. Inclusion in this directory is not an endorsement.